Arzneimittel für Ipratropiumbromid

AOK PLUS - Die Gesundheitskasse für Sachsen und Thürigen·Dresden, Germany·Deadline Sep 30, 2027 · 329 days left·Open·Supplies

Registrieren zum Speichern Open documents

Structured notice only

Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

46/100

Opportunity Score

Needs reviewHigh complexity

SuppliesOpen

Warum diese Bewertung?

Chance

46 / 100

Komplexität

68 / 100

Risikofaktoren

The notice provides no guaranteed quantity or minimum purchase volume, so expected revenue cannot be reliably forecast.

The buyer may terminate the open-house procedure early, particularly after exclusive rebate agreements are concluded; e...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Eckdaten der Ausschreibung

Öffentlicher Auftraggeber: AOK PLUS - Die Gesundheitskasse für Sachsen und Thürigen
Land: Deutschland
CPV: 33600000 - Pharmaceutical products
Frist: Sep 30, 2027

Überblick

Moderate opportunity

Wichtige Fakten

Supplies contract
1 lot
Duration until Sep 2027
Conclusion of non-exclusive pharmaceutical rebate agreements under § 130a(8) SGB V for Ipratropiumbromide medicines, ATC R03BB01.
Metered-dose inhaler dosage forms are excluded.

Vollständige Zusammenfassung anzeigen

Open-house framework-style participation opportunity for pharmaceutical entrepreneurs offering Ipratropiumbromide medicines under ATC R03BB01, excluding metered-dose inhalers. Participation is open to all eligible pharmaceutical entrepreneurs accepting fixed contract terms; there is no exclusivity, no guaranteed volume, and no individual negotiation. The procurement documents and discount terms were not provided for analysis. The structured data and XML notice contain inconsistencies regarding buyer address, electronic submission wording, EU funding, and certain dates.

Risiken

The notice provides no guaranteed quantity or minimum purchase volume, so expected revenue cannot be reliably forecast.

The buyer may terminate the open-house procedure early, particularly after exclusive rebate agreements are concluded; e...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

The participant must be a pharmaceutical entrepreneur within the meaning of § 4(18) AMG in relation to the offered medicines.
The pharmaceutical entrepreneur must have its seat within the scope of the AMG, another EU Member State, or another EEA contracting state, as stated in the notice.
Local representatives may participate only if they themselves qualify as pharmaceutical entrepreneurs for the offered medicines.

Anforderungen können unvollständig sein.

Auftraggeber

Name

AOK PLUS - Die Gesundheitskasse für Sachsen und Thürigen

Ort

Dresden, DEU

E-Mail

[email protected]

Website

www.aok.de/pk/plus/

Auftraggeberprofil

Profil öffnen

Kennung

DE256878834

Tätigkeit

Health

Lose (1)

LOT-0001

Ipratropiumbromide pharmaceutical products under an open-house rebate agreement

Non-exclusive rebate agreement under § 130a(8) SGB V for medicines containing Ipratropiumbromide, ATC R03BB01, excluding the metered-dose inhaler dosage form. Participation is open during the participation period to pharmaceutical entrepreneurs meeting and accepting the participation requirements. Quantities are unknown and no minimum purchase volume is guaranteed.

SuppliesFrameworkEU fundedElectronic submission

Ort

Dresden, Germany

Dauer

Sep 2026 - Sep 2027

Kategorie

Pharmaceutical products

Frist

Deadline Sep 30, 2027

Vergabedetails

Veröffentlichungsdatum: 09 Jul 2026
Sprachen: German

Referenzmetadaten

Rechtsgrundlage: 32014L0024

Referenz-IDs

Ausschreibungs-ID: 478099-2026

Dokumente (1)

Vergabedokument 1